DIAGNOSTIC_TEST · Unmapped registry intervention
MRI of the Brain
Find medicine records ·
Find other trials using this name
Clinical trial
Reducing the Incidence of Symptomatic Brain Metastases With MRI Surveillance
NCT05692635
Drugs and interventions used in this trial
4 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
OTHER · Unmapped registry intervention
Blood draws
Find medicine records ·
Find other trials using this name
OTHER · Unmapped registry intervention
Quality of Life Questionnaires
Find medicine records ·
Find other trials using this name
DRUG · Unmapped registry intervention
Gadolinium
Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedReducing the Incidence of Symptomatic Brain Metastases With MRI Surveillance
Design: INTERVENTIONAL · Status: RECRUITING · Phase: PHASE2
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Brain Metastasesunresolved
Nonsmall Cell Lung Cancer Stage IIIunresolved
Interventions
Sponsors & collaborators
Wake Forest University Health Scienceslead sponsor
National Cancer Institute (NCI)collaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT05692635 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.